Recogen 2000IU Injection

About Recogen 2000IU Injection

Recogen 2000IU is an injection that contains the generic medicine Erythropoietin, a substance that helps the body make red blood cells. It is used in certain kinds of anemia, and the treating doctor decides how it is given.

There are 8 brands of Erythropoietin listed in Bangladesh.

What is Recogen 2000IU Injection?

Recogen 2000IU is an injection from Advanced Chemical Industries PLC that contains Erythropoietin, a medicine that supports the production of red blood cells. It belongs to a group of drugs used for anemia linked to long-term kidney failure and for anemia in some cancer patients whose anemia is caused by chemotherapy. Because it is given by injection, it is handled by a doctor or a trained health worker. The dose, the schedule and how long treatment continues are set by the doctor, who also checks your response with blood tests.

Uses of Recogen 2000IU

Recogen 2000IU is used to treat anemia associated with chronic renal failure, both in patients who are on dialysis and in those who are not. It is also used for anemia in patients with certain non-myeloid cancers when the anemia is due to chemotherapy given at the same time. It is not a general tonic for tiredness, and the doctor decides whether it suits your condition.

How to use Recogen 2000IU

Recogen 2000IU is given as an injection by a doctor or a trained health worker, either into a vein or under the skin, depending on the doctor's plan. You should not try to inject it yourself unless a health professional has taught you how. The dose and how often it is given are decided by the doctor, based on blood tests and your condition. Never change the amount or the schedule on your own.

Side effects of Recogen 2000IU

Common side effects include headache, dizziness, fever, feeling unwell and joint pain. Raised blood pressure is the most common cardiovascular effect, and some people notice palpitations. Nausea, vomiting, loss of appetite and diarrhea can occur. Allergic reactions are possible. Tell your doctor promptly about severe headache, swelling, or any sign of an allergic reaction, and seek urgent care if breathing becomes difficult.

Safety and precautions

Recogen 2000IU is not for people with uncontrolled high blood pressure, or with a known allergy to mammalian cell-derived products or to Erythropoietin or any ingredient of the preparation. Use it with caution if you have controlled high blood pressure, ischemic vascular disease, a history of seizures, or a suspected allergy to the product. Iron stores are checked before and during treatment. In pregnancy it is used only if clearly needed, and caution is advised during breastfeeding. Tell your doctor about all your conditions and medicines first.

Frequently asked questions

How is Recogen 2000IU given?

It is given as an injection by a doctor or trained health worker, into a vein or under the skin. The doctor decides the dose and how often it is given, guided by blood tests. Do not change the schedule yourself, and ask your doctor if you have questions about your treatment plan.

What side effects should I watch for, and when should I call the doctor?

Watch for headache, dizziness, fever, feeling unwell, joint pain, palpitations, nausea, vomiting, loss of appetite or diarrhea. Call your doctor if these bother you or do not settle. Get urgent help for severe headache, swelling, or signs of an allergic reaction such as trouble breathing.

What does the generic name Erythropoietin mean?

Erythropoietin is the generic name of the active substance in Recogen 2000IU. It is a medicine that supports the body's production of red blood cells. The brand name identifies this particular product, while the generic name tells you which active medicine it contains. Ask your pharmacist if you want to know more.

Who should ask a doctor before using it?

Ask your doctor first if you have high blood pressure, ischemic vascular disease, a history of seizures, or a known or suspected allergy to the product or its ingredients. Also tell the doctor if you are pregnant, planning pregnancy or breastfeeding, so the benefits and risks can be discussed.

Indications

Erythropoietin is indicated for the treatment of-
  • Anemia associated with Chronic Renal Failure, including patients on dialysis and patients not on dialysis.
  • Anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.
  • ... Read more
Erythropoietin is indicated for the treatment of-
  • Anemia associated with Chronic Renal Failure, including patients on dialysis and patients not on dialysis.
  • Anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.
  • Anemic patients (hemoglobin >10 to <13 g/dL) are scheduled to undergo elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions.
  • Anemia related to therapy with zidovudine in HIV-infected patients.

Dosage & Administration

Treatment of anemia in chronic renal failure: Erythropoietin is administered to maintain hemoglobin concentration between 11 to 12 g/dl and hematocrit of 33-36 % in adults.

Starting dose:
  • Adult: Usually 50 to 100 lU/kg three times in a week (TIW) by IV or Subcutaneous route.
  • Pediatric: 50 lU/kg TIW by IV or Subcutaneous route.
Dose adjustment: Dose should be increased if hematocrit doses not increase by 5 to 6 points after 8 weeks therapy, and hematocrit is below suggested target range. Dose should be reduced when hematocrit approaches 36% or hematocrit increases >4 points in any 2-week period.

Maintenance dose: Maintenance dose must be individualized for each patient. In patients undergoing dialysis, the median maintenance dose is 75 lU/kg TIW, with a range from 12.5 to 525 lU/kg TIW as directed by the physician. In CRF patients not on dialysis, maintenance dose is 75 to 150 lU/kg/week.

Treatment of Anemia in Cancer Patients on Chemotherapy:

Starting dose:
  • Adult: 150 lU/kg TIW by Subcutaneous route or 40,000 IU Subcutaneous route weekly.
  • Pediatric: 25 to 300 lU/kg 3 to 7 times per week by Subcutaneous or IV route.
Dose adjustment: If the response is not satisfactory, the dose should be increased to 300 lU/kg TIW. If the hematocrit exceeds 40%, the dose should be withheld until the hematocrit falls to 36%.The dose should be reduced to 25% when treatment is resumed and titrated to maintain the desired hematocrit.

Surgery Patients: The recommended dose is 300 lU/kg/day subcutaneously for 10 days before surgery, on the day of surgery, and for 4 days after surgery. An alternate dose schedule is 600 lU/kg subcutaneously in once weekly dose (21, 14, and 7 days before surgery) plus a fourth dose on the day of surgery.

Zidovudine-treated HIV-infected Patients:
Starting dose
  • Adult: 100 lU/kg as an IV or Subcutaneous injection TIW for 8 weeks.
  • Pediatric: 50 to 400 lU/kg 2 to 3 times per week by Subcutaneous or IV route.
Dose adjustment: If the response is not satisfactory, the dose should be increased by 50-1001U/kg TIW. Response should be evaluated every 4 to 8 weeks thereafter and the dose adjusted accordingly by 50 to 100 lU/kg increments TIW.

Maintenance dose: The dose is titrated to maintain the hematocrit between 33-36%.

Contraindications

Erythropoietin is contraindicated in patients with:
  • Uncontrolled hypertension
  • Known hypersensitivity to mammalian cell-derived products
  • A history of hypersensitivity to Erythropoietin or any component of the preparation.

Side Effects

General: Headache, dizziness, fever, malaise, arthralgia and occasionally hyperkalemia. Cardiovascular: Hypertension is the most common side effect, palpitations. Gastrointestinal: Nausea, vomiting, anorexia and diarrhea may occur occasionally. Allergic reactions.

Pregnancy & Lactation

Pregnancy Category C. Since there are no controlled studies of erythropoietin in pregnant women, and because animal reproduction studies are not always predictive of human responses, erythropoietin should be used during pregnancy only if clearly needed. It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when erythropoietin is administered to a nursing woman.

Precautions & Warnings

Erythropoietin should be used with caution in those patients with controlled hypertension, ischaemic vascular disease, history of seizures, or suspected allergy to the product.

Iron evaluation: Prior to and during Erythropoietin therapy, the patient's iron stores, including transferrin saturation and serum ferritin, should be evaluated. Transferrin saturation should be at least 20%, and ferritin should be at least 100 ng/ml. Virtually all patients will require supplemental Iron to increase or maintain transferrin saturation to levels that will adequately support erythropoiesis.

Overdose Effects

Doses of up to 1500 lU/kg TIW for 3 to 4 weeks have been administered to adults without any direct toxic effects. If the suggested target range is exceeded, drug therapy may be temporarily withheld until the hemoglobin returns to the suggested target range. If polycythemia is of concern, phlebotomy may be indicated to decrease the hemoglobin.

Storage Conditions

Erythropoietin should be stored at 2°C to 8°C. Protect from light. Do not freeze & avoid shaking.

Alternative brands of Erythropoietin

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.